Nerve growth factor (NGF) is a neurotrophic factor essential for the development and survival of neurons, and is also an important mediator of inflammation. It is released by airway cells stimulated by interleukin (IL)-1b. As IL-1b induces airway hyperresponsiveness (AHR) to the tachykinin NK-1 receptor agonist [Sar 9 ,Met(O 2 ) 11 ]-substance P in human isolated bronchi, the aim of this study was to determine whether IL-1b was able to induce NGF release from isolated bronchi, and whether NGF might participate into IL-1b-induced AHR.IL-1b (10 ng?mL -1 ; 21˚C; 15 h) increased the release of NGF from human isolated bronchi in vitro, and, in organ bath studies, the response of human bronchi to [Sar 9 ,Met(O 2 ) 11 ]-substance P (0.1 mm). A significant correlation was found between these responses. AHR induced by IL-1b was abolished by a blocking anti-human NGF antibody. Finally, NGF (1 ng?mL -1 ; 37˚C; 0.5 h) by itself induced a significant increase in [Sar 9 ,Met(O 2 ) 11 ]-substance P responsiveness. By contrast, it did not change the maximal contraction to acetylcholine.In conclusion, the present study clearly demonstrated that nerve growth factor may participate in the airway hyperresponsiveness induced by interleukin-1b, which supports the neuro-immune cross-talk that may be active in the development of hyperresponsiveness in the human airways, and suggests nerve growth factor is active in the airways in asthma.